These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34772313)

  • 1. Effectiveness of collaboration between oncology pharmacists and anaesthesiologists for inpatient cancer pain management: A pilot study in Taiwan.
    Chen KJ; Tai YT; Chang EH; Kuo LN; Kuo CN
    J Int Med Res; 2021 Nov; 49(11):3000605211055415. PubMed ID: 34772313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary intervention incorporating pharmacists in management of opioid-naïve patients with moderate to severe cancer pain.
    Ding H; Zheng X; Kong S; Gong L; Ding Q; Huang P
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13225. PubMed ID: 31971652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Continuous Pharmacist Interventions on Pain Control and Side Effect Management in Outpatients with Cancer Receiving Opioid Treatments.
    Yamada M; Matsumura C; Jimaru Y; Ueno R; Takahashi K; Yano Y
    Biol Pharm Bull; 2018; 41(6):858-863. PubMed ID: 29863074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacists' interventions on drug-related problems and drug costs in patients with cancer pain.
    Zhang P; Lv D; Zhao J; Sun S; Li L; Liao Y
    Int J Clin Pharm; 2021 Oct; 43(5):1274-1282. PubMed ID: 33625653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary exploration on the role of clinical pharmacists in cancer pain pharmacotherapy.
    Su YJ; Yan YD; Wang WJ; Xu T; Gu ZC; Bai YR; Lin HW
    Ann Palliat Med; 2020 Sep; 9(5):3070-3077. PubMed ID: 32787363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist-managed immune checkpoint inhibitor toxicities.
    Le S; Chang B; Pham A; Chan A
    J Oncol Pharm Pract; 2021 Apr; 27(3):596-600. PubMed ID: 32507100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
    Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
    J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician-pharmacist collaboration on chronic non-cancer pain management during the opioid crisis: A qualitative interview study.
    Kang I; Urick B; Vohra R; Ives TJ
    Res Social Adm Pharm; 2019 Aug; 15(8):1027-1031. PubMed ID: 31053466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital cancer pain management by electronic health record-based automatic screening.
    Shin J; Ko H; Kim JA; Song YM; An JS; Nam SJ; Lee J
    Am J Manag Care; 2018 Nov; 24(11):e338-e343. PubMed ID: 30452201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of pharmacist interventions as part of a multidisciplinary cancer pain management team in a Chinese academic medical center.
    Liu J; Wang C; Chen X; Luo J; Xie J; Li S; Hu J; Shi C
    J Am Pharm Assoc (2003); 2020; 60(1):76-80. PubMed ID: 31669418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
    BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of an innovative pharmacist-led inpatient opioid de-escalation intervention in post-operative orthopedic patients.
    Bui T; Grygiel R; Konstantatos A; Christelis N; Liew S; Hopkins R; Dooley M
    J Opioid Manag; 2020; 16(3):167-176. PubMed ID: 32421837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion effects of an inpatient hospice unit on improving the parent hospital's pain management of terminally ill cancer patients not receiving hospice care in Taiwan.
    Tang ST
    Cancer Nurs; 2010; 33(3):221-7. PubMed ID: 20357653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge and attitudes of health-care providers toward cancer pain management: a comparison of physicians, nurses, and pharmacists in the state of New Hampshire.
    Furstenberg CT; Ahles TA; Whedon MB; Pierce KL; Dolan M; Roberts L; Silberfarb PM
    J Pain Symptom Manage; 1998 Jun; 15(6):335-49. PubMed ID: 9670634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of inpatient and high-risk medicine pharmacist interventions associated with insulin prescribing for hospital inpatients with diabetes.
    Zipf N; Grant L; Robinson B; Teasdale T; Grant G; Hattingh HL
    Int J Clin Pharm; 2021 Oct; 43(5):1420-1425. PubMed ID: 34247328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative practice model for management of pain in patients with cancer.
    Hammer KJ; Segal EM; Alwan L; Li S; Patel AM; Tran M; Marshall HM
    Am J Health Syst Pharm; 2016 Sep; 73(18):1434-41. PubMed ID: 27605322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tramadol with or without paracetamol (acetaminophen) for cancer pain.
    Wiffen PJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012508. PubMed ID: 28510996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service.
    Xue Y; Schulman-Green D; Czaplinski C; Harris D; McCorkle R
    Clin J Oncol Nurs; 2007 Oct; 11(5):687-95. PubMed ID: 17962176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
    Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
    Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.